Vesicular monoamine transporters expression in pheochromocytomas and paragangliomas according to scintigraphy and positron emission tomography behavior
- 1 February 2022
- journal article
- research article
- Published by Edizioni Minerva Medica in The Quarterly Journal of Nuclear Medicine and Molecular Imaging
- Vol. 65 (4), 396-401
- https://doi.org/10.23736/s1824-4785.16.02887-9
Abstract
Article: Vesicular monoamine transporters expression in pheochromocytomas and paragangliomas according to scintigraphy and positron emission tomography behavior - The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 December;65(4):396-401 - Minerva Medica - JournalsKeywords
This publication has 10 references indexed in Scilit:
- Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine TransportersJournal of Nuclear Medicine, 2015
- Paraganglioma and phaeochromocytoma: from genetics to personalized medicineNature Reviews Endocrinology, 2014
- Expression of somatostatin receptors, dopamine D2 receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomasEndocrine-Related Cancer, 2011
- 6-18F-Fluoro-l-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to123I-Metaiodobenzyl-Guanidine Scintigraphy in the Detection of Extraadrenal and Hereditary Pheochromocytomas and Paragangliomas: Correlation with Vesicular Monoamine Transporter ExpressionJournal of Clinical Endocrinology & Metabolism, 2010
- Clinically Guided Genetic Screening in a Large Cohort of Italian Patients with Pheochromocytomas and/or Functional or Nonfunctional ParagangliomasJournal of Clinical Endocrinology & Metabolism, 2009
- 6-l-18F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical ApplicationsJournal of Nuclear Medicine, 2008
- Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2Acta Endocrinologica, 2005
- Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transportersBritish Journal of Cancer, 2003
- Nuclear medicine imaging of neuroendocrine tumoursAnnals of Oncology, 2001
- Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.Proceedings of the National Academy of Sciences of the United States of America, 1996